135 related articles for article (PubMed ID: 26948312)
1. The interaction between histamine H1 receptor and μ- opioid receptor in scratching behavior in ICR mice.
Nakasone T; Sugimoto Y; Kamei C
Eur J Pharmacol; 2016 Apr; 777():124-8. PubMed ID: 26948312
[TBL] [Abstract][Full Text] [Related]
2. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in mice.
Yamamoto A; Kuyama S; Kamei C; Sugimoto Y
Eur J Pharmacol; 2010 Feb; 627(1-3):162-6. PubMed ID: 19900440
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of passive cutaneous anaphylaxis-associated scratching behavior by mu-opioid receptor antagonists in ICR mice.
Inagaki N; Nakamura N; Nagao M; Kawasaki H; Nagai H
Int Arch Allergy Immunol; 2000 Dec; 123(4):365-8. PubMed ID: 11146395
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of scratching behavior in ADJM mice (atopic dermatitis from Japanese mice).
Nakasone T; Sato T; Matsushima Y; Inoue T; Kamei C
Immunopharmacol Immunotoxicol; 2015 Apr; 37(2):202-6. PubMed ID: 25578901
[TBL] [Abstract][Full Text] [Related]
5. Involvement of peripheral mu opioid receptors in scratching behavior in mice.
Yamamoto A; Sugimoto Y
Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827
[TBL] [Abstract][Full Text] [Related]
6. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice.
Kamei J; Nagase H
Eur J Pharmacol; 2001 Apr; 418(1-2):141-5. PubMed ID: 11334876
[TBL] [Abstract][Full Text] [Related]
7. Effects of ICI204,448, naloxone methiodide and levocetirizine on the scratching behavior induced by a κ-opioid antagonist, nor-BNI, in ICR mice.
Nakasone T; Wakuda H; Sugimoto Y; Kamei C
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):292-295. PubMed ID: 28745076
[TBL] [Abstract][Full Text] [Related]
8. Evidence for separate involvement of different mu-opioid receptor subtypes in itch and analgesia induced by supraspinal action of opioids.
Andoh T; Yageta Y; Konno M; Yamaguchi-Miyamoto T; Takahata H; Nojima H; Nemoto H; Kuraishi Y
J Pharmacol Sci; 2008 Apr; 106(4):667-70. PubMed ID: 18403901
[TBL] [Abstract][Full Text] [Related]
9. Differential itch- and pain-related behavioral responses and µ-opoid modulation in mice.
Akiyama T; Carstens MI; Carstens E
Acta Derm Venereol; 2010 Nov; 90(6):575-81. PubMed ID: 21057739
[TBL] [Abstract][Full Text] [Related]
10. Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice.
Inagaki N; Nakamura N; Nagao M; Musoh K; Kawasaki H; Nagai H
Eur J Pharmacol; 1999 Feb; 367(2-3):361-71. PubMed ID: 10079012
[TBL] [Abstract][Full Text] [Related]
11. Pentacyclic triterpenoids, alpha,beta-amyrins, suppress the scratching behavior in a mouse model of pruritus.
Oliveira FA; Lima-Junior RC; Cordeiro WM; Vieira-Júnior GM; Chaves MH; Almeida FR; Silva RM; Santos FA; Rao VS
Pharmacol Biochem Behav; 2004 Aug; 78(4):719-25. PubMed ID: 15301927
[TBL] [Abstract][Full Text] [Related]
12. Intracisternal, but not intrathecal, injection of naloxone inhibits cutaneous itch-related response in mice.
Kuraishi Y; Yageta Y; Konno M; Andoh T; Yamaguchi-Miyamoto T; Nojima H
Biol Pharm Bull; 2008 Nov; 31(11):2143-5. PubMed ID: 18981588
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 induces itch and pain in the mouse cheek model.
Gomes LO; Hara DB; Rae GA
Life Sci; 2012 Oct; 91(13-14):628-33. PubMed ID: 22483687
[TBL] [Abstract][Full Text] [Related]
14. Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice.
Sugimoto Y; Umakoshi K; Nojiri N; Kamei C
Eur J Pharmacol; 1998 Jun; 351(1):1-5. PubMed ID: 9698198
[TBL] [Abstract][Full Text] [Related]
15. Scratching behavior and Fos expression in superficial dorsal horn elicited by protease-activated receptor agonists and other itch mediators in mice.
Akiyama T; Merrill AW; Zanotto K; Carstens MI; Carstens E
J Pharmacol Exp Ther; 2009 Jun; 329(3):945-51. PubMed ID: 19293390
[TBL] [Abstract][Full Text] [Related]
16. Effect of Brazilian propolis on scratching behavior induced by compound 48/80 and histamine in mice.
Shinmei Y; Hossen MA; Okihara K; Sugimoto H; Yamada H; Kamei C
Int Immunopharmacol; 2004 Oct; 4(10-11):1431-6. PubMed ID: 15313440
[TBL] [Abstract][Full Text] [Related]
17. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.
Togashi Y; Umeuchi H; Okano K; Ando N; Yoshizawa Y; Honda T; Kawamura K; Endoh T; Utsumi J; Kamei J; Tanaka T; Nagase H
Eur J Pharmacol; 2002 Jan; 435(2-3):259-64. PubMed ID: 11821035
[TBL] [Abstract][Full Text] [Related]
18. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
[TBL] [Abstract][Full Text] [Related]
19. The role of central mu opioid receptors in opioid-induced itch in primates.
Ko MC; Song MS; Edwards T; Lee H; Naughton NN
J Pharmacol Exp Ther; 2004 Jul; 310(1):169-76. PubMed ID: 15044556
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.
Umeuchi H; Kawashima Y; Aoki CA; Kurokawa T; Nakao K; Itoh M; Kikuchi K; Kato T; Okano K; Gershwin ME; Miyakawa H
Eur J Pharmacol; 2005 Aug; 518(2-3):133-9. PubMed ID: 16055114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
